Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

CDC-Authored Genomics and Precision Health Publications Database|Home|Public Health Genomics and Precision Health Knowledge Base (PHGKB)

CDC-Authored Genomics and Precision Health Publications Database


Last data update: Nov 04, 2024. (Total: 6390 publications)
   dataset
Filtered By:
Records 1-19 (of 19 Records)
Query Trace: Fleming-Dutra KE[original query]
Interim effectiveness of updated 2023-2024 (monovalent XBB.1.5) COVID-19 vaccines against COVID-19-associated hospitalization among adults aged ≥18 years with immunocompromising conditions - VISION Network, September 2023-February 2024
Link-Gelles R , Rowley EAK , DeSilva MB , Dascomb K , Irving SA , Klein NP , Grannis SJ , Ong TC , Weber ZA , Fleming-Dutra KE , McEvoy CE , Akinsete O , Bride D , Sheffield T , Naleway AL , Zerbo O , Fireman B , Hansen J , Goddard K , Dixon BE , Rogerson C , Fadel WF , Duszynski T , Rao S , Barron MA , Reese SE , Ball SW , Dunne MM , Natarajan K , Okwuazi E , Shah AB , Wiegand R , Tenforde MW , Payne AB .
MMWR Morb Mortal Wkly Rep 2024 73 (12) 271-276 type
Early estimates of updated 2023-2024 (monovalent XBB.1.5) COVID-19 vaccine effectiveness against symptomatic SARS-CoV-2 infection attributable to co-circulating Omicron variants among immunocompetent adults - increasing community access to testing program, United States, September 2023-January 2024
Link-Gelles R , Ciesla AA , Mak J , Miller JD , Silk BJ , Lambrou AS , Paden CR , Shirk P , Britton A , Smith ZR , Fleming-Dutra KE .
MMWR Morb Mortal Wkly Rep 2024 73 (4) 77-83 type
Development of COVID-19 vaccine policy - United States, 2020-2023
Oliver SE , Wallace M , Twentyman E , Moulia DL , Godfrey M , Link-Gelles R , Meyer S , Fleming-Dutra KE , Hall E , Wolicki J , MacNeil J , Bell BP , Lee GM , Daley MF , Cohn A , Wharton M .
Vaccine 2023 type
Building the U.S. COVID-19 vaccine effectiveness program: Past successes and future directions
Link-Gelles R , Britton A , Fleming-Dutra KE .
Vaccine 2023
Effectiveness of a bivalent mRNA vaccine dose against symptomatic SARS-CoV-2 infection among U.S. Healthcare personnel, September 2022-May 2023
Plumb ID , Briggs Hagen M , Wiegand R , Dumyati G , Myers C , Harland KK , Krishnadasan A , James Gist J , Abedi G , Fleming-Dutra KE , Chea N , Lee JE , Kellogg M , Edmundson A , Britton A , Wilson LE , Lovett SA , Ocampo V , Markus TM , Smithline HA , Hou PC , Lee LC , Mower W , Rwamwejo F , Steele MT , Lim SC , Schrading WA , Chinnock B , Beiser DG , Faine B , Haran JP , Nandi U , Chipman AK , LoVecchio F , Eucker S , Femling J , Fuller M , Rothman RE , Curlin ME , Talan DA , Mohr NM .
Vaccine 2023 type
Effectiveness of a messenger RNA vaccine booster dose against coronavirus disease 2019 among US healthcare personnel, October 2021-July 2022
Plumb ID , Mohr NM , Hagen M , Wiegand R , Dumyati G , Harland KK , Krishnadasan A , Gist JJ , Abedi G , Fleming-Dutra KE , Chea N , Lee J , Barter D , Brackney M , Fridkin SK , Wilson LE , Lovett SA , Ocampo V , Phipps EC , Marcus TM , Smithline HA , Hou PC , Lee LC , Moran GJ , Krebs E , Steele MT , Lim SC , Schrading WA , Chinnock B , Beiser DG , Faine B , Haran JP , Nandi U , Chipman AK , LoVecchio F , Talan DA , Pilishvili T .
Open Forum Infect Dis 2023 10 (10) ofad457 type
Effectiveness of monovalent and bivalent mRNA vaccines in preventing COVID-19-associated emergency department and urgent care encounters among children aged 6 months-5 years - VISION Network, United States, July 2022-June 2023
Link-Gelles R , Ciesla AA , Rowley EAK , Klein NP , Naleway AL , Payne AB , Kharbanda A , Natarajan K , DeSilva MB , Dascomb K , Irving SA , Zerbo O , Reese SE , Wiegand RE , Najdowski M , Ong TC , Rao S , Stockwell MS , Stephens A , Goddard K , Martinez YC , Weber ZA , Fireman B , Hansen J , Timbol J , Grannis SJ , Barron MA , Embi PJ , Ball SW , Gaglani M , Grisel N , Arndorfer J , Tenforde MW , Fleming-Dutra KE .
MMWR Morb Mortal Wkly Rep 2023 72 (33) 886-892
Interim recommendations for use of bivalent mRNA COVID-19 vaccines for persons aged 6 months - United States, April 2023
Moulia DL , Wallace M , Roper LE , Godfrey M , Rosenblum HG , Link-Gelles R , Britton A , Daley MF , Meyer S , Fleming-Dutra KE , Oliver SE , Twentyman E .
MMWR Morb Mortal Wkly Rep 2023 72 (24) 657-662
Effectiveness of booster doses of monovalent mRNA COVID-19 vaccine against symptomatic severe acute respiratory syndrome coronavirus 2 infection in children, adolescents, and adults during omicron subvariant BA.2/BA.2.12.1 and BA.4/BA.5 predominant periods
Ciesla AA , Wiegand RE , Smith ZR , Britton A , Fleming-Dutra KE , Miller J , Accorsi EK , Verani JR , Shang N , Derado G , Pilishvili T , Link-Gelles R .
Open Forum Infect Dis 2023 10 (5) ofad187
Effectiveness of BNT162b2 COVID-19 Vaccination in Children and Adolescents.
Klein NP , Demarco M , Fleming-Dutra KE , Stockwell MS , Kharbanda AB , Gaglani M , Rao S , Lewis N , Irving SA , Hartmann E , Natarajan K , Dalton AF , Zerbo O , DeSilva MB , Konatham D , Stenehjem E , Rowley EAK , Ong TC , Grannis SJ , Sloan-Aagard C , Han J , Verani JR , Raiyani C , Dascomb K , Reese SE , Barron MA , Fadel WF , Naleway AL , Nanez J , Dickerson M , Goddard K , Murthy K , Grisel N , Weber ZA , Dixon BE , Patel P , Fireman B , Arndorfer J , Valvi NR , Griggs EP , Hallowell C , Embi PJ , Ball SW , Thompson MG , Tenforde MW , Link-Gelles R .
Pediatrics 2023 151 (5) type
Early Estimates of Bivalent mRNA Booster Dose Vaccine Effectiveness in Preventing Symptomatic SARS-CoV-2 Infection Attributable to Omicron BA.5- and XBB/XBB.1.5-Related Sublineages Among Immunocompetent Adults - Increasing Community Access to Testing Program, United States, December 2022-January 2023.
Link-Gelles R , Ciesla AA , Roper LE , Scobie HM , Ali AR , Miller JD , Wiegand RE , Accorsi EK , Verani JR , Shang N , Derado G , Britton A , Smith ZR , Fleming-Dutra KE .
MMWR Morb Mortal Wkly Rep 2023 72 (5) 119-124 type
Invasive Group A Streptococcal Penicillin Binding Protein 2× Variants Associated with Reduced Susceptibility to β-Lactam Antibiotics in the United States, 2015-2021.
Chochua S , Metcalf B , Li Z , Mathis S , Tran T , Rivers J , Fleming-Dutra KE , Li Y , McGee L , Beall B .
Antimicrob Agents Chemother 2022 66 (9) e0080222
Effectiveness of COVID-19 mRNA vaccines against infection during an outbreak of SARS-CoV-2 Beta (B.1.351) variant in a skilled nursing facility - Virginia, March-April 2021.
Moline HL , Keaton A , Rice W , Varghese J , Deng L , Waters A , Barringer A , Winston D , Fields V , Slifka KJ , Verani JR , Schrag SJ , Jernigan J , Tate JE , Fleming-Dutra KE .
Clin Infect Dis 2022 75 S155-S158 type
Continued Increase of Erythromycin- and Clindamycin-Nonsusceptibility among Invasive Group A Streptococci Driven by Genomic Clusters, USA, 2018-2019.
Li Y , Rivers J , Mathis S , Li Z , McGee L , Chochua S , Metcalf BJ , Fleming-Dutra KE , Nanduri SA , Beall B .
Clin Infect Dis 2022 76 (3) e1266-e1269 type
Association of Prior BNT162b2 COVID-19 Vaccination With Symptomatic SARS-CoV-2 Infection in Children and Adolescents During Omicron Predominance.
Fleming-Dutra KE , Britton A , Shang N , Derado G , Link-Gelles R , Accorsi EK , Smith ZR , Miller J , Verani JR , Schrag SJ .
JAMA 2022 327 (22) 2210-2219 type
Association of COVID-19 Vaccination With Symptomatic SARS-CoV-2 Infection by Time Since Vaccination and Delta Variant Predominance.
Britton A , Fleming-Dutra KE , Shang N , Smith ZR , Dorji T , Derado G , Accorsi EK , Ajani UA , Miller J , Schrag SJ , Verani JR .
JAMA 2022 327 (11) 1032-1041
A Veterans' Healthcare Administration (VHA) antibiotic stewardship intervention to improve outpatient antibiotic use for acute respiratory infections: A cost-effectiveness analysis.
Yoo M , Madaras-Kelly K , Nevers M , Fleming-Dutra KE , Hersh AL , Ying J , Haaland B , Samore M , Nelson RE .
Infect Control Hosp Epidemiol 2021 43 (10) 1-7
SARS-CoV-2 transmission in a Georgia school district - United States, December 2020-January 2021.
Gettings JR , Gold JAW , Kimball A , Forsberg K , Scott C , Uehara A , Tong S , Hast M , Swanson MR , Morris E , Oraka E , Almendares O , Thomas ES , Mehari L , McCloud J , Roberts G , Crosby D , Balajee A , Burnett E , Chancey RJ , Cook P , Donadel M , Espinosa C , Evans ME , Fleming-Dutra KE , Forero C , Kukielka EA , Li Y , Marcet PL , Mitruka K , Nakayama JY , Nakazawa Y , O'Hegarty M , Pratt C , Rice ME , Rodriguez Stewart RM , Sabogal R , Sanchez E , Velasco-Villa A , Weng MK , Zhang J , Rivera G , Parrott T , Franklin R , Memark J , Drenzek C , Hall AJ , Kirking HL , Tate JE , Vallabhaneni S .
Clin Infect Dis 2021 74 (2) 319-326 type
Incidence of pharyngitis, sinusitis, acute otitis media, and outpatient antibiotic prescribing preventable by vaccination against group A Streptococcus in the United States.
Lewnard JA , King LM , Fleming-Dutra KE , Link-Gelles R , Van Beneden CA .
Clin Infect Dis 2020 73 (1) e47-e58
TOP